You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Awaiting product image

Article: What do we still need to know about the treatment of RCC?

€3.03

SKU: product-article-10861 Category: General

Description
Reviews (0)

Description

What do we still need to know about the treatment of RCC?

Reviews

There are no reviews yet.

Be the first to review “Article: What do we still need to know about the treatment of RCC?”

You must be logged in to post a review.

Top